ArticleJournal of cancer research and clinical oncology2022

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia.

Maximilian Fleischmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.